Grabar Law Office Is Investigating Claims On Behalf Of Long-Term Shareholders Of Atkore Inc. (Nyse: Atkr), Crocs, Inc. (Nasdaq: Crox), Methode Electronics, Inc. (Nyse: Mei), And Ocugen, Inc. (Nasdaq: Ocgn)

Atkore Inc. :

PHILADELPHIA, Feb. 24, 2025 (GLOBE NEWSWIRE) — Grabar Law Office is investigating claims on behalf of Atkore Inc. shareholders. The investigation concerns whether certain officers of Atkore have breached their fiduciary duties owed to the company.

Current Atkore shareholders who have held Atkore stock since on or before February 1, 2024, or alternatively, who purchased shares between February 1, 2024 and February 3, 2025, are encouraged to visit https://grabarlaw.com/the-latest/atkore-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.

WHY: An underlying securities fraud class action alleges that the Atkore Inc., through certain of its executives, violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Atkore engaged in an anticompetitive price-fixing scheme that artificially inflated the price of PVC Pipes; (2) in turn, Atkore reaped significant, unsustainable financial benefits from its anticompetitive conduct; (3) as Atkore's price-fixing scheme was exposed, the Company and its price fixing co-conspirators were no longer able to artificially inflate the price of PVC Pipes, resulting in a substantial decrease in the price of PVC Pipes; (4) Atkore's business and operations were negatively impacted; and (5) as a result of the above, Defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On February 4, 2025, when Atkore announced its financial results for the first quarter of fiscal year 2025, reporting net sales of $661.6 million-below analysts' estimates of $680.7 million. Additionally, Atkore significantly reduced its adjusted earnings per share (EPS) and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) guidance for the rest of fiscal year 2025. During the corresponding earnings call that same day, CFO Deitzer disclosed that Atkore's "plastic pipe and conduit product category declined mid-single digits during the quarter[,]" compared to "high single digits in the prior year." CFO Deitzer also attributed the guidance reduction to the forthcoming poor performance of Atkore's PVC business, stating, "I'd say roughly $75 million or 3/4 of that is on the PVC side."

On this news, the price of Atkore common stock fell $15.59 per share, or nearly 20%, from a closing price of $79.72 per share on February 3, 2025, to a closing price of $64.13 per share on February 4, 2025

WHAT YOU CAN DO NOW: Current Atkore shareholders who have held Atkore stock since on or before February 1, 2024, or alternatively, who purchased shares between February 1, 2024 and February 3, 2025, are encouraged to visit https://grabarlaw.com/the-latest/atkore-shareholder-investigation/, contact us at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more about their rights. $ATKR #ATKORE

You may be able to seek damages, corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to you whatsoever.

Crocs, Inc. :

Current shareholders who acquired Crocs, Inc. shares prior to November 3, 2022, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them whatsoever. You do not need to have lost money on your investment in order to participate. To learn more visit https://grabarlaw.com/the-latest/crocs-shareholder-investigation/ or contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call us at 267-507-6085.

WHY: Grabar Law Office is investigating claims on behalf of shareholders of Crocs, Inc. . The investigation concerns whether certain officers and directors of Crocs breached their fiduciary duties.

On February 17, 2022, Crocs acquired100% of the equity of a privately-owned casual footwear brand business (“HEYDUDE”), pursuant to a securities purchase agreement entered into on December 22, 2021. HEYDUDE is engaged in the business of distributing and selling casual footwear under the brand name “HEYDUDE.” The majority of HEYDUDE sales are currently in the United States.

Croc’s acquisition of HEYDUDE, is now at the center of a securities fraud class action complaint. According to the underlying class action complaint, it is alleged that Croc’s, Inc. , via certain of its officers and directors, made materially false and/or misleading statements, as well as failed to disclose material adverse facts, about the Company’s business and operations. Specifically, Defendants misrepresented and/or failed to disclose: (1) the nature and sustainability of HEYDUDE’s revenue growth by concealing that 2022 revenue growth was driven, in large part, by the Company’s efforts to stock third-party wholesalers and retailers following the February 2022 acquisition of HEYDUDE; (2) that as the Company’s retail partners began to destock this excess inventory, waning product demand further negatively impacted the Company’s financial results; and (3) that, as a result, Defendants’ representations about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

WHAT YOU CAN DO NOW: Current Crocs shareholders who have held shares of the Company’s stock since prior to November 3, 2022, can seek corporate reforms, the return of funds, and a court approved incentive award if appropriate.

If you would like to learn more at no cost to you, you are encouraged to visit https://grabarlaw.com/the-latest/crocs-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call us at 267-507-6085. $CROX #Crocs

Methode Electronics, Inc. :

Grabar Law Office is investigating claims on behalf of Methode Electronics Inc. shareholders. The investigation concerns whether certain officers of Methode Electronics have breached the fiduciary duties they owed to the company.

Current Methode Electronics, Inc. shareholders who have held Methode Electronics shares since prior to June 23, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award - all at no cost to them whatsoever. To learn more visit: https://grabarlaw.com/the-latest/methode-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.

Why: A recently filed underlying securities fraud class action complaint alleges that Methode Electronics, via certain of its officers and directors, made false and/or misleading statements and/or failed to disclose that: (i) Methode Electronics had lost highly skilled and experienced employees during the COVID-19 pandemic necessary to successfully complete Methode Electronics’ transition from its historic low mix, high volume production model to a high mix, low production model at its Monterrey facility; (ii) Methode Electronics’ attempts to replace its General Motors center console production with more diversified, specialized products for a wider array of vehicle manufacturers and OEMs, in particular in the electric vehicle (“EV”) space, had been plagued by production planning deficiencies, inventory shortages, vendor and supplier problems, and, ultimately, botched execution of Methode Electronics’ strategic plans; (iii) Methode Electronics’ manufacturing systems at its critical Monterrey facility suffered from a variety of logistical defects, such as improper system coding, shipping errors, erroneous delivery times, deficient quality control systems, and failures to timely and efficiently procure necessary raw materials; (iv) Methode Electronics had fallen substantially behind on the launch of new EV programs out of its Monterrey facility, preventing Methode Electronics from timely receiving revenue from new EV program awards; and (v) as a result, Methode Electronics was not on track to achieve the 2023 diluted earnings-per-share guidance or the 3-year 6% organic sales compound annual growth rate represented to investors and such estimates lacked a reasonable factual basis.

Current Methode Electronics shareholders who have held Methode Electronics stock since prior to June 23, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever.

If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/methode-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. #Methode #MethodeElectronics $MEI

Ocugen, Inc. :

Grabar Law Office is investigating whether officers and directors of Ocugen, Inc. breached their fiduciary duties owed to the company.

If you have held Ocugen shares since prior to May 8, 2020 and would like to learn more about the investigation, your rights, and potential for recovery, please visit https://grabarlaw.com/the-latest/Ocugen-Shareholder-Investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com or call 267-507-6085.

WHY. After market hours on April 1, 2024, Ocugen filed a Notification of Late Filing on Form 12b-25 with the SEC, stating that "in connection with the preparation of the financial statements of the Company for the year ended December 31, 2023, the Company identified certain accounting errors relating to the application of U.S. GAAP to certain agreements with one of its business partners related to a collaboration agreement. As a result, the Company intends to restate its financial statements for the year ended December 31, 2022 and for each of the first three quarters of 2022 and 2023 in the 2023 Form 10-K, the review and preparation of which is currently ongoing."

A recently filed securities fraud class action complaint alleges that Ocugen, via certain of its officers and directors, made materially false and/or misleading statements and/or failed to disclose that: (1) Ocugen’s financial statements from May 8, 2020 to the present were materially misstated; (2) Ocugen did not have adequate internal controls; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

WHAT YOU CAN DO NOW: Current Ocugen shareholders who have held Ocugen shares since prior to May 8, 2020, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.

If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/ocugen-shareholder-investigation/, contact us at jgrabar@grabarlaw.com, or call 267-507-6085. $OCGN #Ocugen

Attorney Advertising Disclaimer

Contact:

Joshua H. Grabar, Esq.

Grabar Law Office

One Liberty Place

1650 Market Street, Suite 3600

Philadelphia, PA 19103

Tel: 267-507-6085

Email: jgrabar@grabarlaw.com

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your Crocs, Inc. investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=131862&wire=1

or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.

NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Crocs, Inc. between November 3, 2022 and October 28, 2024, inclusive (the “Class Period”), of the important March 24, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Crocs common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Crocs class action, go to https://rosenlegal.com/submit-form/?case_id=33986 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 24, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants, throughout the Class Period, failed to disclose to investors that: (1) the nature and sustainability of HEYDUDE’s revenue growth by concealing that 2022 revenue growth was driven, in large part, by the Crocs’ efforts to stock third-party wholesalers and retailers following the February 2022 acquisition of HEYDUDE; (2) Crocs’ retail partners began to destock this excess inventory, waning product demand further negatively impacted Crocs’ financial results; and (3) that, as a result, defendants’ representations about Crocs’ business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Crocs class action, go to https://rosenlegal.com/submit-form/?case_id=33986 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com for more information.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

case@rosenlegal.com

www.rosenlegal.com

SAN FRANCISCO, Feb. 24, 2025 (GLOBE NEWSWIRE) — Investors in Crocs, Inc. suffered yet another loss on Oct. 29, 2024 after the company prepared investors for disappointing Q4 and FY 2024 financial results that, in turn, sent shares crashing $26.47 (-19%). According to the company, the culprit was its HEYDUDE operating segment performance. Now a class action lawsuit has been filed focused on the propriety of Crocs’ disclosures about sales practices within its HEYDUDE operating segment, which Crocs acquired in mid-February 2022.

More specifically, during the Class Period, Crocs CEO Andrew Rees assured investors that “our wholesale customers are being really prudent in terms of how they manage their business, in terms of managing their overall inventory levels[]” and “we’re not going to play the game of forcing inventory into them and getting them overstocked.”

Hagens Berman urges investors who purchased Crocs shares and suffered substantial losses to submit your losses now.

Class Period: Nov. 3, 2022 – Oct. 28, 2024

Lead Plaintiff Deadline: Mar. 24, 2025

Visit: www.hbsslaw.com/investor-fraud/crox

Contact the Firm Now: CROX@hbsslaw.com | 844-916-0895

Crocs, Inc. (CROX) Securities Class Action:

But, the complaint alleges, Crocs misled investors by concealing the fact that the strong revenue growth exhibited by its HEYDUDE segment following its acquisition was largely driven by a conscious decision by Crocs management to aggressively stock its third-party wholesaler pipeline with HEYDUDE products, regardless of the level of retail demand being experienced by those wholesalers.

Investors began to learn the truth on Apr. 27, 2023, when Rees revealed during Crocs’ Q1 2023 earnings call that much of HEYDUDE’s revenue growth during 2022 was attributable to efforts to stock wholesalers with HEYDUDE products and was not necessarily indicative of actual downstream retail sales.

Then, during a June 7, 2023 industry conference, Crocs management revealed that $70 million of Q2 2022 and $60 million of Q3 2022 HEYDUDE sales “was pipeline fill” and “[y]ou don’t sell through that all immediately.”

More bad news arrived on July 27, 2023, when Crocs revealed that pipeline fill during 2022 was $220 million, said “wholesale growth is expected to be low,” and slashed its HEYDUDE revenue growth outlook.

Next, during its Nov. 2, 2023 Q3 2023 earnings call, Crocs again slashed its HEYDUDE revenue outlook and blamed the cut on the company’s need to proactively lower in-channel inventories.

Most recently, on Oct. 29, 2024, Crocs disclosed that for Q4 2024 HEYDUDE revenue would be down 6% to 4% compared to the prior year period and for FY 2024 HEYDUDE revenue would be down 14.5% compared to the prior year. Management said, “from a HEYDUDE perspective, we have had excess inventories in the market and we’ve been aggressively trying to work those down this year[]” and “we absolutely shipped too much product” in 2022 and 2023.

Each of these events sent the price of Crocs shares significantly lower.

“We’re investigating whether Crocs may have intentionally misled investors about the sustainability of its growth through improper channel-stuffing,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in Crocs and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now.

If you’d like more information and answers to frequently asked questions about the Crocs case and our investigation, read more.

Whistleblowers: Persons with non-public information regarding Crocs should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email CROX@hbsslaw.com.

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contact:

Reed Kathrein, 844-916-0895